Indications And Dose
Low sexual desire in postmenopausal women (administered on expert advice) ▶BY TRANSDERMAL APPLICATION ▶Adult: Apply 50 mg every week, the contents of a 5-g sachet or 5-g tube (containing 50 mg/5 g of testosterone) to be divided for daily dosing and applied to non-hair areas, such as the abdomen or upper thighs, over the period of 1 week TESTAVAN ® Hypogonadism due to androgen deficiency in men ▶BY TRANSDERMAL APPLICATION ▶Adult: Apply 23 mg once daily; increased in steps of 23 mg, adjusted according to response; maximum 69 mg per day DOSE EQUIVALENCE AND CONVERSION ▶For Testavan ® One pump actuation delivers 1.15 g of gel containing 23 mg of testosterone. TESTIM ® Hypogonadism due to testosterone deficiency in men ▶BY TRANSDERMAL APPLICATION ▶Adult: Apply 50 mg once daily, subsequent application adjusted according to response; maximum 100 mg per day DOSE EQUIVALENCE AND CONVERSION ▶For Testim ® One tube of 5 g contains 50 mg testosterone. TESTOGEL ® 16.2MG/G Hypogonadism due to androgen deficiency in men ▶BY TRANSDERMAL APPLICATION ▶Adult: Apply 40.5 mg once daily; increased in steps of 20.25 mg, adjusted according to response; maximum 81 mg per day DOSE EQUIVALENCE AND CONVERSION ▶For Testogel ® 16.2 mg/g One pump actuation delivers 1.25 g of gel containing 20.25 mg of testosterone. TESTOGEL ® 50MG/5G Hypogonadism due to androgen deficiency in men ▶BY TRANSDERMAL APPLICATION ▶Adult: Apply 50 mg once daily; increased in steps of 25 mg, adjusted according to response; maximum 100 mg per day DOSE EQUIVALENCE AND CONVERSION ▶For Testogel ® 50 mg/5g One sachet of 5 g contains 50 mg of testosterone. TOSTRAN ® Hypogonadism due to testosterone deficiency in men ▶BY TRANSDERMAL APPLICATION ▶Adult: Apply 60 mg once daily, subsequent application adjusted according to response; maximum 80 mg per day DOSE EQUIVALENCE AND CONVERSION ▶For Tostran ® 1 g of gel contains 20 mg testosterone. l UNLICENSED USE g Testosterone is used for the treatment of low sexual desire in postmenopausal women, l but is not licensed for this indication.
Source page 833

